Table 2.
n | Value | % | |
---|---|---|---|
Age, years | 29 | ||
Mean | 65,4 | ||
Range | 43–80 | ||
Sex | 29 | ||
Male | 12 | 41,3 | |
Female | 17 | 58,7 | |
Primary tumor | |||
GI (+pancreas) | 6 | 20,7 | |
Breast | 5 | 17,2 | |
Respiratory + ENT | 4 | 13,8 | |
Other solid tumor | 5 | 17,2 | |
Leukemia | 5 | 17,2 | |
Lymphoma | 3 | 10,3 | |
Myeloma | 1 | 3,4 | |
Time from diagnosis, months | 29 | ||
Mean | 44 | ||
Range | 0.8–186.4 | ||
Performance status | 28 | ||
Mean | 2,4 | ||
Range | 0–4 | ||
0–1 | 5 | 17,2 | |
2 | 6 | 20,7 | |
3 | 14 | 28,0 | |
4 | 3 | 10,3 | |
Number of treatment lines | 28 | ||
Mean | 2.8 | ||
Range | 0–6 | ||
0 | 2 | 6,8 | |
1 | 3 | 10,3 | |
2 | 9 | 31,0 | |
3 | 5 | 17,2 | |
4 | 5 | 17,2 | |
>4 | 5 | 17,2 | |
Quality of lifea | 29 | ||
Mean | 2,9 | ||
Range | 0,2–9 | ||
0–2,4 | 16 | ||
2,5–4,9 | 8 | ||
5–7,4 | 3 | ||
7,5–10 | 2 | ||
Estimated Life expectancy | 29 | ||
<15 days | 1 | ||
15 days–3 months | 10 | ||
3–6 months | 8 | ||
6–12 months | 5 | ||
Not answered | 5 |
aestimated between 0 and 10 on a visual scale by physician